Preview

Regulatory Research and Medicine Evaluation

Advanced search

Major challenges in evaluating the quality of pharmaceutical substances (the assay)

Abstract

Common topical issues of the quality assessment of pharmaceutical substances in terms of «Assay», are related to the compliance of actual test results to assay requirements as well as to the proper elaboration of normative documents (completeness, accuracy of the descriptions of analytical methods) and the appropriate test conditions validation with the materials in the scope of the mentioned regulatory documents. It was shown that an objective assessment of the quantitative content of an active ingredient in pharmaceutical substance of synthetic or mineral origin depends largely on the choice of the analytical method, use of the appropriate techniques considering the materials included in the monographs of the State Pharmacopoeia the Russian Federation and leading foreign pharmacopoeias.

About the Authors

T. N. Bokovikova
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation


E. P. Gernikova
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation


L. A. Stronova
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation


M. V. Agapkina
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation


O. A. Baturina
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation


S. A. Nemykina
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation


O. A. Matveeva
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation


N. P. Sadchikova
I. M. Sechenov First Moscow State Medical University
Russian Federation


References

1. Mironov AN, ed. Guidance on the examination of medicines. V. 2. Moscow: Grif i K; 2013.

2. The State Pharmacopoeia of the Russian Federation. 13th edition. Moscow; 2015. Available from: http://femb.ru/feml (in Russian).

3. European Pharmacopoeia. 8th ed. Supplement 8.2. European Directorate for the Quality of Medicines. Available from: http://online.edqm.eu/entry.htm.

4. British Pharmacopoeia. 2015. The British Pharmacopoeia Commission. Available from: https://www.pharmacopoeia.com.

5. United States Pharmacopeia. 38th edition. Available from: http://www.uspnf.com/uspnf.

6. The State Pharmacopoeia of the Russian Federation. 12th edition. Part 1. Moscow: NCESMP; 2007 (in Russian).

7. The State Pharmacopoeia of the USSR. 11th edition. V. 1, 2. Moscow: Meditsina; 1989 (in Russian).

8. Belikov VG. Pharmaceutical Chemistry: Textbook for pharmaceutical institutes and pharmaceutical faculties. Moscow: Vysshaya shkola; 1993 (in Russian).

9. Haritonov SV. Ion-selective electrodes for determination of medicines. Uspehi himii 2007; 76(4): 398–432 (in Russian).

10. Merkulov VA, Sakanyan EI, Volkova RA, Klimov VI, Shemeryankina TB, Yashkir VA. Pharmacopoeial reference standards and their implementation in the national system of standardization of medicines. Pharmaceutical Chemistry Journal 2016; 50(4): 40–3 (in Russian).

11. Merkulov VA, Sakanyan EI, Klimov VI, Shemeryankina TB, Yashkir VA, Barmin AB. Modern approaches to the development of standard models for assessing the quality of pharmaceutical substances. Pharmaceutical Chemistry Journal 2015; 49(11): 54–6 (in Russian).


Review

For citations:


Bokovikova T.N., Gernikova E.P., Stronova L.A., Agapkina M.V., Baturina O.A., Nemykina S.A., Matveeva O.A., Sadchikova N.P. Major challenges in evaluating the quality of pharmaceutical substances (the assay). The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2016;(3):37-41. (In Russ.)

Views: 634


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 3034-3062 (Print)
ISSN 3034-3453 (Online)